Construction of recombinant adenovirus co-expressing M1 and HA genes of influenza virus type A.
- Author:
Jian-Qiang GUO
1
;
Li-Hong YAO
;
Ai-Jun CHEN
;
Yi XU
;
Run-Qing JIA
;
Hong BO
;
Jie DONG
;
Jian-Fang ZHOU
;
Yue-Long SHU
;
Zhi-Qing ZHANG
Author Information
1. State Key Laboratory for Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
- Publication Type:Journal Article
- MeSH:
Adenoviridae;
genetics;
metabolism;
Antibodies, Viral;
Gene Expression;
genetics;
Genetic Vectors;
pharmacology;
Humans;
Influenza A Virus, H5N1 Subtype;
drug effects;
Influenza Vaccines;
Plasmids;
pharmacology;
Recombinant Fusion Proteins;
genetics;
metabolism;
Viral Vaccines;
pharmacology
- From:
Chinese Journal of Virology
2009;25(2):107-112
- CountryChina
- Language:Chinese
-
Abstract:
Based on the human H5N1 influenza virus strain A/Anhui/1/2005, recombinant adenovirus co-expressing M1 and HA genes of H5N1 influenza virus was constructed using an internal ribosome entry site (IRES) sequence to link the two genes. The M1 and HA genes of H5N1 influenza virus were amplified by PCR and subcloned into pStar vector separately. Then the M1-IRES-HA fragment was amplified and subcloned into pShuttle-CMV vector, the shuttle plasmid was then linearized and transformed into BJ5183 bacteria which contained backbone vector pAd-Easy. The recombinant vector pAd-Easy was packaged in 293 cells to get recombinant adenovirus Ad-M1/HA. CPE was observed after 293 cells were transfected by Ad-M1/HA. The co-expression of M1 and HA genes was confirmed by Western-blot and IFA (immunofluorescence assay). The IRES containing recombinant adenovirus allowed functional co-expression of M1 and HA genes and provided the foundation for developing new influenza vaccines with adenoviral vector.
